Generics
News
Italy asked to comply with marketing rules for generics
posted 07/02/2012
The news that the European Commission (EC) had finally issued a formal call on 26 January 2012 for Italy to comply with EU ru... 
Generic and biosimilar user fee recommendations sent to Congress
posted 07/02/2012
FDA has sent recommendations for user fee programmes, including those covering generic and biosimilar drugs, to US Congress.... 
Watson expands in Asia with Ascent Pharmahealth
posted 27/01/2012
US generics manufacturer Watson Pharmaceuticals announced on 24 January 2012 that it had acquired Ascent Pharmahealth, the Au... 
Teva outlines expansion plans in Asia
posted 23/01/2012
Generics giant Teva is looking for deals in Asia, which the company believes will see strong future expansion in the use of g... 
Generic nasal spray approved by FDA
posted 20/01/2012
India-based generics manufacturer Wockhardt announced on 10 January 2012 that it had received final approval from FDA for mar... |
Research
Generics market to experience strong growth in 2010–17
posted 07/02/2012
The global market for generic drugs will experience strong growth in the coming years due to patent expiries of blockbuster d... 
Factors important for generics substitution in Finland
posted 26/01/2012
What factors do patients take into account when deciding to accept or reject generics substitution? This is the question aske... 
Translational research to uncover new uses for generics
posted 04/11/2011
On the surface, generic compounds and translational medicines could not appear more different. However, in April 2011, the US... 
Generics saved US$931 billion over last 10 years
posted 07/10/2011
On 21 September 2011, the US Generic Pharmaceutical Association (GPhA) released the results of an independent analysis showin... 
Generic atorvastatin may be better than Crestor
posted 30/09/2011
AstraZeneca’s leading cholesterol drug Crestor (rosuvastatin) failed to show a statistically significant benefit over Pfizer’... |
General
The pharmaceutical market in Brazil
posted 15/12/2011
The Brazilian pharmaceutical market is the third largest in the Americas region, after Canada and USA, it ranks first in the... 
European Commission investigates Johnson & Johnson and Novartis over delaying generics
posted 09/12/2011
As part of its ongoing antitrust investigations, the European Commission (EC) announced on 21 October 2011 that it is looking... 
Quality by design for generics by 2013
posted 09/12/2011
Quality by design (QbD) is already being implemented by FDA for new drug applications, but now, in an attempt to prepare gene...
European Commission to investigate patent settlements again
posted 09/12/2011
The European Commission (EC) has once again requested information from pharmaceutical companies regarding patent settlement a... 
Row continues over drug shortages
posted 02/11/2011
Unhappiness about persistent drug shortages is becoming more acute, both in Europe and the US. Hospitals in The Netherlands a... |